Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma

M.D. Anderson Cancer Center · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
recurrent b-cell non-hodgkin lymphoma, refractory b-cell non-hodgkin lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 895420
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.